Contribution of bariatric surgery to the comprehension of morbid obesity

Obesity Surgery

Volumn 15, Issue 1, 2005, Pages 3-10

  Marceau, Picard ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Morbid obesity; Thermogenesis

Indexed keywords

GASTROINTESTINAL HORMONE;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CALORIC INTAKE; ENERGY BALANCE; FOOD INTAKE; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; LIPID ABSORPTION; LIPID STORAGE; METABOLIC DISORDER; MORBID OBESITY; PRIORITY JOURNAL; REVIEW; THERMOGENESIS;

BASAL METABOLISM; BILIOPANCREATIC DIVERSION; BODY MASS INDEX; BODY WEIGHT; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; MALE; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 13444262519     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892052993620     Document Type: Review

References (74)

1. Friedman JM. Modern science versus the stigma of obesity. Nat Med 2004; 10: 563-9.
2. Rothwell NJ, Stock MJ. Regulation of energy balance. Ann Rev Nutr 1981; 1: 235-56.
3. Weigle D. Appetite and the regulation of body composition. FASEB J 1994; 8: 302-10.
4. Ravussin E, Lillioja S, Knowler WC et al. Reduced rate of energy expenditure as a risk factor or body-weight gain. N Engl J Med 1988; 318: 467-72.
5. Neumann RO. Experimentalle Beigrage zur lehre von dem taglichen Nahrungsbedarf des menschen unter besonderer Berucksi chtigung der notwentigen Eiweissmenge. Archives of Hygiene 1902; 45: 1.
6. Sims EAH. Experimental obesity, dietary-induced thermogenesis, and their clinical implications. Clin Endocrinol Metab 1976; 5: 377-95.
7. Angel A, Winocur JT, Roncari DAK. Morbid obesity. The problem and its consequences. In: Deitel M, ed. Surgery for the Morbidly Obese Patient. Philadelphia: Lea & Febiger 1989: 20-5.
8. Morgan J, Mumford P. Preliminary studies of energy expenditure in infants under six months of age. Acta Pediatr Scand 1981; 70: 15-9.
9. Bouchard C, Tremblay A, Després JP et al. The response to long term overfeeding in identical twins. N Engl J Med 1990; 332: 1477-82.
10. Wilber JF. Neuropeptides, appetite regulation, and human obesity. JAMA 1991; 266: 257-9.
11. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967: 379-88.
12. Cabanac M, Rabe EF. Influence of a monotonous food and body weight regulation in humans. Physiol Behav 1975; 17: 675-8.
13. Miller DS, Mumford P, Stock MJ. Gluttony 2. Thermogenesis in overeating man. Am J Clin Nutr 1967; 20: 1223-9.
14. Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979; 281: 31-5.
15. York DA, Morgan JB, Taylor TG. The relationship of dietary induces thermogenesis to metabolic efficiency in man. Proc Nutr Soc 1980; 39: 57A.
16. Garrow JS, Blaza SE, Warwick PM et al. Predisposition to obesity. Lancet 1980; 1: 1103-4.
17. Jéquier E, Schutz Y. New evidence for a thermogenic defect in human obesity. Int J Obes 1985; 9: 1-7.
18. Calles-Escandron J, Horton ES. The thermogenic role of exercise in the treatment of morbid obesity: a critical evaluation. Am J Clin Nutr 1992; 55: 533S-537S.
19. Flatt JP. How NOT to approach the obesity problem. Obes Res 1997; 5: 632-3.
20. Stock JM. Gluttony and thermogenesis revisited. Int J Obes 1999; 23: 1105-17.
21. Levine JA, Eberhardt NL, Jensen MD. Role of non-exercise activity thermogenesis in resistance to fat gain in humans. Science 1999; 283: 212-4.
22. Dulloo AG, Jacquet J. An adipose-specific control of thermogenesis in body weight regulation. Int J Obes 2001; 25: S22-S29.
23. Miller DS, Mumford P. Obesity: physical activity and Nutrition. Proc Nutr Soc 1966; 25: 100-7.
24. Rothwell NJ, Stock MJ, Warwick BP. Investigation into the role of insulin in diet-induced thermogenesis in the rat. Proc Nutr Soc 1981; 40: 5A.
25. Tremblay A, Nadeau A, Despres JP et al. Hyperinsulinemia and regulation of energy balance. Am J Clin Nutr 1995; 61: 827-30.
26. Landsberg L, Saville ME, Young JB. Sympathoadrenal system and regulation of thermogenesis. Am J Physiol 1984; 247: E181-189.
27. Stunkard AJ, Harris JR, Pedersen NL et al. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-7.
28. Kaplan ML, Leveille GA. Calorigenic response in obese and nonobese women. Am J Clin Nutr 1976; 29: 1108-13.
29. Astrup A, Andersen T, Christenses NJ et al. Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans. Am J Clin Nutr 1990; 51: 331-7.
30. Geissler CA, Miller DS, Shah M. The daily metabolic rate of the post-obese and the lean. Am J Clin Nutr 1987; 45: 914-20.
31. Andrews F, Jackson F. Increasing fatness inversely related to increase in metabolic rate but directly related to decrease in deep body temperature in young men and women during cold exposure. Ir J Med Sci 1978; 147: 329-30.
32. Pittet P, Chappuis P, Acheson K et al. Thermic effect of glucose in obese subjects studied by direct and indirect calorimetry. Br J Nutr 1976; 35: 281-92.
33. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332: 621-8.
34. Roberts SB, Savage J, Coward WA et al. Energy expenditure and intake in infants born to lean and overweight mothers. N Engl J Med 1988; 318: 461-6.
35. Leibel RL, Hirsch J. Diminished energy requirements in reduced-obese patients. Metabolism 1984; 33: 164-70.
36. Doucet E, St Pierre S, Alméras N et al. Evidence for the existence of adaptive thermogenesis during weight loss. Br J Nutr 2001; 85: 715-23.
37. Sims EAH, Danforth E Jr, Horton ES et al. Endocrine and metabolic effects of experimental obesity in man. Recent Progress in Hormone Research 1973; 29: 457-96.
38. Swinburn BA, Nyomba BL, Saad MF et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-73.
39. Eckel RH. Insulin resistance: An adaptation for weight maintenance. Lancet 1992; 340: 1452-3.
40. Goris AHC, Westerterp-Plantenga MS, Wesberterp KR. Undereating and undercording of habitual food intake in obese men: selective under-reporting of fat intake. Am J Clin Nutr 2000; 71: 130-4.
41. Hill RJ, Davies PSW. The validity of self reported energy intake as determined using the doubly labeled water technique. Br J Nutr 2001; 85: 415-30.
42. Jeffery RW, Epstein LH, Wilson GT et al. Long-term maintenance of weight loss: current status. Health Psychology 2000; 19 (1 S): 5-16.
43. Coughlin K, Bell RM, Bivins BA et al. Preoperative and postoperative assessment of nutrient intakes in patients who have undergone gastric bypass surgery. Arch Surg 1983; 118: 813-6.
44. Miskoviak J, Honore K, Larsen L et al. Food intake before and after gastroplasty for morbid obesity. Scand J Gastroenterol 1985; 20: 925-8.
45. Brolin RE, Kenler HA, Gorman JH et al. Long-limb gastric bypass in the superobese. Ann Surg 1992; 215: 387-95.
46. Mitchell JE, Lancaster KL, Burgard MA et al. Long-term follow-up of patients' status after gastric bypass. Obes Surg 2001; 11: 464-8.
47. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it. An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-52.
48. Scopinaro N, Gianetta E, Adami GF et al. Biliopancreatic diversion for obesity at 18 years. Surgery 1996; 119: 261-8.
49. Biron S, Mould FH, Lebel S et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg 2004; 14: 160-4.
50. Scopinaro N, Gianetta E, Civalleri D et al. Biliopancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 26: 618-20.
51. Marceau P, Biron S, Bourque RA et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993; 3: 29-35.
52. Hess DS, Hess DN. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8: 267-82.
53. Marceau P, Mould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-54.
54. Greco AV, Tataranni PA, Tacchino RM et al. Daily energy expenditure in post obese patients. Int J Obes 1993; 17: 27-30.
55. Scopinaro N, Marinari G, Camerini G et al. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg 2000; 10: 436-41.
56. Sarson DL, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981; 5: 471-80.
57. Scopinaro N, Adami, GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936-46.
58. Adami GF, Cordera R, Gamerini G. Long term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes 2004; 28: 671-3.
59. Marceau P, Hould FS, Lebel S. Malabsorptive obesity surgery. Surg Clin North Am 2001; 81: 1113-27.
60. Sirinek Kr, O'Dorisio TM, Hill D et al. Hyperinsulinism, glucose-dependent insulinotropic polypeptide and the enteroinsular axis in morbidly obese patients before and after gastric bypass. Surgery 1986; 100: 781-7.
61. Kellum JM, Kuemmerle JF, O'Dorisio TM et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763-71.
62. Näslund E, Backman L, Holst JJ et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 1998; 8: 253-60.
63. Adami GF, Compostano A, Gandolfo P et al. Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity. Eur Surg Res 1996; 28: 295-8.
64. Adami GF, Campositano A, Bessarione D et al. Resting energy expenditure in long-term postobese subjects after weight normalization by dieting or biliopancreatic diversion. Obes Surg 1993; 3: 397-9.
65. Mason EE. Heal transposition and enteroglucagon/GLP1 in obesity (and diabetic?) Surgery. Obes Surg 1999; 9: 223-8.
66. Holst JJ. Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterology 1994; 107: 1848-55.
67. Drucker DJ. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Exp Opin Invest Drug 2003; 12: 87-100.
68. Ballinger A. Gastric inhibitory polypeptide links over-nutrition to obesity. Gut 2003; 52: 319-20.
69. Zander M, Madsbad S, Madsen JL et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 2002; 359: 824-30.
70. Patriti A, Facchiano E, Sanna A et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004; 14: 840-8.
71. Sirinek Kr, O'Dorisio TM, Howe B et al. Neurotensin, vasoactive intestinal peptide, and Roux-en-Y gastrojejunostomy. Arch Surg 1985; 120: 605-9.
72. Meryn S, Stein D, Straus EW. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. Int J Obes 1986; 10: 37-42.
73. Kral JG, Thung SN, Biron S et al. Effects of surgical treatments of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2003; 135: 48-58.
74. Larrad Jiménez A, Sánchez Cabezudo C, de Quadros Borrajo PP et al. Course of metabolic syndrome following the biliopancreatic diversion of Larrad. Obes Surg 2004; 14: 1176-81.